Lonza AG
⚠️ Moderate Risk
FEI: 3002930340 • Visp, Valais • SWITZERLAND
FEI Number
3002930340
Location
Visp, Valais
Country
SWITZERLANDAddress
Lonzastrasse 2, , Visp, Valais, Switzerland
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DIRSEXMPT
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NO LICENSE
The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/25/2022 | 64UQS99INHIBITOR N.E.C. | 2280DIRSEXMPT | Division of Northern Border Imports (DNBI) |
| 10/25/2022 | 64UQS99INHIBITOR N.E.C. | 2280DIRSEXMPT | Division of Northern Border Imports (DNBI) |
| 12/5/2019 | 64EIS99ENZYME N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 4/18/2017 | 56EIA80TETRACYCLINE (TETRACYCLINES) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 10/14/2015 | 57YL99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C. | 71NO LICENSE | Division of Northeast Imports (DNEI) |
Frequently Asked Questions
What is Lonza AG's FDA import refusal history?
Lonza AG (FEI: 3002930340) has 5 FDA import refusal record(s) in our database, spanning from 10/14/2015 to 10/25/2022.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Lonza AG's FEI number is 3002930340.
What types of violations has Lonza AG received?
Lonza AG has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Lonza AG come from?
All FDA import refusal data for Lonza AG is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.